UNIVERSITY OF FLORIDA
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1853-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ufl.edu
Satralizumab in Aneurysmal Subarachnoid Hemorrhage
Early Phase 1
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2023-02-14
- Last Posted Date
- 2024-08-15
- Lead Sponsor
- University of Florida
- Registration Number
- NCT05727657
- Locations
- 🇺🇸
University of Florida (UF) Health Shands Hospital, Gainesville, Florida, United States
Cortical Processes During Walking Post-stroke
Active, not recruiting
- Conditions
- First Posted Date
- 2023-02-02
- Last Posted Date
- 2024-08-01
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 30
- Registration Number
- NCT05710029
- Locations
- 🇺🇸
University of Florida, Gainesville, Florida, United States
Baby 2 Baby Beneficial Bacteria
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-01-30
- Last Posted Date
- 2024-02-07
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 60
- Registration Number
- NCT05703659
- Locations
- 🇺🇸
University of Florida, Gainesville, Florida, United States
AMPLIFY Study: Transcutaneous Spinal Direct Current Stimulation to Enhance Locomotor Rehabilitation After SCI
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-01-26
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 18
- Registration Number
- NCT05700942
- Locations
- 🇺🇸
Brooks Rehabilitation Hospital, Jacksonville, Florida, United States
Exercise to ReGain Stamina and Energy (The EXERGISE Study)
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-01-13
- Last Posted Date
- 2023-12-08
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 24
- Registration Number
- NCT05684367
- Locations
- 🇺🇸
Institute on Aging; University of Florida, Gainesville, Florida, United States
Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI
Phase 4
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-01-12
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 90
- Registration Number
- NCT05681702
- Locations
- 🇺🇸
University of Florida, Jacksonville, Florida, United States
AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-12-30
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 12
- Registration Number
- NCT05669339
- Locations
- 🇺🇸
University of Florida, Gainesville, Florida, United States
A Study of Oral IRAK-4 Inhibitor CA-4948 in Combination With Pembrolizumab Following Stereotactic Radiosurgery in Patients With Melanoma Brain Metastases
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-12-30
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 29
- Registration Number
- NCT05669352
- Locations
- 🇺🇸
University of Florida, Gainesville, Florida, United States
Septorhinoplasty Post-operative Pain Control With SPG Nerve Block
Phase 4
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-12-28
- Last Posted Date
- 2024-05-30
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 120
- Registration Number
- NCT05667324
- Locations
- 🇺🇸
UF Health of University of Florida, Gainesville, Florida, United States
Effects of Exercise on Dystonia Pathophysiology
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-12-23
- Last Posted Date
- 2024-04-09
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 56
- Registration Number
- NCT05663840
- Locations
- 🇺🇸
University of Florida, Gainesville, Florida, United States
© Copyright 2024. All Rights Reserved by MedPath